{"id":4038,"date":"2020-12-28T14:00:00","date_gmt":"2020-12-28T14:00:00","guid":{"rendered":"https:\/\/www.nanexa.com\/mfn_news\/vd-brev-fran-nanexas-vd-david-westberg\/"},"modified":"2020-12-28T14:00:00","modified_gmt":"2020-12-28T14:00:00","slug":"vd-brev-fran-nanexas-vd-david-westberg","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/vd-brev-fran-nanexas-vd-david-westberg\/","title":{"rendered":"Vd-brev fr\u00e5n Nanexas vd David Westberg"},"content":{"rendered":"
\n

David Westberg, vd f\u00f6r Nanexa AB, summerar 2020 och blickar fram\u00e5t mot 2021.<\/strong><\/p>\n<\/div>\n

\n

\u201c<\/strong>F\u00f6r alla oss som arbetar i Nanexa har 2020 varit ett omv\u00e4lvande \u00e5r med en helt fantastisk utveckling av bolaget och jag vill ta tillf\u00e4llet att s\u00e5 h\u00e4r i slutet av \u00e5ret passa p\u00e5 att tacka alla Nanexas medarbetare f\u00f6r starka insatser under \u00e5ret.<\/p>\n

Vi har under 2020 tagit st\u00f6rre steg mot att bli ett riktigt l\u00e4kemedelsbolag \u00e4n n\u00e5got \u00e5r tidigare. Det \u00e4r n\u00e5gra omr\u00e5den jag fr\u00e4mst vill lyfta fram och det \u00e4r omr\u00e5den som jag vet \u00e4r av stor betydelse f\u00f6r v\u00e5ra partners och f\u00f6r utvecklingen av v\u00e5ra egna produktprojekt\u201d, skriver Nanexas vs David Westberg.<\/p>\n

L\u00e4s mer i bifogat vd-brev.
\u00a0\u00a0<\/p>\n<\/div>\n

\n

F\u00f6r mer information kontakta:<\/strong><\/p>\n

\n

David Westberg \u2013 VD, Nanexa AB (publ)\u00a0
Telefon: 0709-42 83 03
E-post:\u00a0david.westberg@nanexa.se<\/a>
www.nanexa.com<\/a><\/p>\n

Erik Penser Bank \u00e4r bolagets Certified Adviser och n\u00e5s p\u00e5 08-463 83 00, e-post: certifiedadviser@penser.se<\/p>\n<\/div>\n

\n

Om Nanexa AB (publ)<\/strong><\/p>\n

\n

Nanexa AB \u00e4r ett nanoteknologiskt drug delivery-f\u00f6retag fokuserat p\u00e5 utvecklingen av PharmaShell\u00ae, ett nytt och banbrytande drug delivery-system med stor\u00a0potential inom ett flertal substanstyper och indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae utvecklar Nanexa egna projekt och har samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland\u00a0AstraZeneca.<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

Vd Brev PM 201228<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

David Westberg, vd f\u00f6r Nanexa AB, summerar 2020 och blickar fram\u00e5t mot 2021.<\/p>\n","protected":false},"template":"","class_list":["post-4038","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nVd-brev fr\u00e5n Nanexas vd David Westberg - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/vd-brev-fran-nanexas-vd-david-westberg\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vd-brev fr\u00e5n Nanexas vd David Westberg - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"David Westberg, vd f\u00f6r Nanexa AB, summerar 2020 och blickar fram\u00e5t mot 2021.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/vd-brev-fran-nanexas-vd-david-westberg\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/vd-brev-fran-nanexas-vd-david-westberg\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/vd-brev-fran-nanexas-vd-david-westberg\\\/\",\"name\":\"Vd-brev fr\u00e5n Nanexas vd David Westberg - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2020-12-28T14:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/vd-brev-fran-nanexas-vd-david-westberg\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/vd-brev-fran-nanexas-vd-david-westberg\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/vd-brev-fran-nanexas-vd-david-westberg\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Vd-brev fr\u00e5n Nanexas vd David Westberg\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vd-brev fr\u00e5n Nanexas vd David Westberg - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/vd-brev-fran-nanexas-vd-david-westberg\/","og_locale":"sv_SE","og_type":"article","og_title":"Vd-brev fr\u00e5n Nanexas vd David Westberg - Nanexa AB","og_description":"David Westberg, vd f\u00f6r Nanexa AB, summerar 2020 och blickar fram\u00e5t mot 2021.","og_url":"https:\/\/nanexa.com\/mfn_news\/vd-brev-fran-nanexas-vd-david-westberg\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/vd-brev-fran-nanexas-vd-david-westberg\/","url":"https:\/\/nanexa.com\/mfn_news\/vd-brev-fran-nanexas-vd-david-westberg\/","name":"Vd-brev fr\u00e5n Nanexas vd David Westberg - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2020-12-28T14:00:00+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/vd-brev-fran-nanexas-vd-david-westberg\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/vd-brev-fran-nanexas-vd-david-westberg\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/vd-brev-fran-nanexas-vd-david-westberg\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Vd-brev fr\u00e5n Nanexas vd David Westberg"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/4038","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=4038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}